Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Return on Sales (2022 - 2025)

Gossamer Bio's Return on Sales history spans 4 years, with the latest figure at 3.42% for Q4 2025.

  • For Q4 2025, Return on Sales rose 10.0% year-over-year to 3.42%; the TTM value through Dec 2025 reached 3.57%, down 305.0%, while the annual FY2025 figure was 3.51%, 302.0% down from the prior year.
  • Return on Sales reached 3.42% in Q4 2025 per GOSS's latest filing, up from 3.63% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 51.86% in Q4 2023 to a low of 3.97% in Q1 2025.
  • Average Return on Sales over 4 years is 10.65%, with a median of 14.53% recorded in 2023.
  • Peak YoY movement for Return on Sales: soared 3531bps in 2023, then crashed -5538bps in 2024.
  • A 4-year view of Return on Sales shows it stood at 16.55% in 2022, then soared by 213bps to 51.86% in 2023, then tumbled by -107bps to 3.52% in 2024, then grew by 3bps to 3.42% in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Return on Sales are 3.42% (Q4 2025), 3.63% (Q3 2025), and 3.33% (Q2 2025).